Characteristics of the immune system during pregnancy and pregnancy with autoimmune diseases

doi:10.3877/cma.j.issn.2095-3259.2019.02.009

Abstract

Abstract:

Pregnancy is a complex physiological process in which a series of changes in the immune system is to maintain the mother′s immune tolerance to the " non-self" component of the fetus and the normal response to external stimuli. At the same time, during pregnancy, the incidence of certain autoimmune diseases increases, or stable disease develops or progresses, which are also closely related to the special changes in the immune system during pregnancy. However, the exact mechanism of its occurrence during pregnancy is still unclear. This article reviews the literature on the changes in the immune system during pregnancy and the immunological basis of autoimmune diseases in pregnancy.

Key words: Autoimmune diseases, Immune system, Pregnancy

Yangtengyu Liu, Xiaoxia Zuo. Characteristics of the immune system during pregnancy and pregnancy with autoimmune diseases[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2019, 08(02): 103-107.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhckjjdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-3259.2019.02.009

https://zhckjjdzzz.cma-cmc.com.cn/EN/Y2019/V08/I02/103

References 46

[1]	Galli SJ, Borregaard N, Wynn TA. Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils [J]. Nat Immunol, 2011, 12(11): 1035-1044.
[2]	Nagamatsu T, Schust DJ. The contribution of macrophages to normal and pathological pregnancies [J]. Am J Reprod Immunol, 2010, 63(6): 460-471.
[3]	Care AS, Diener KR, Jasper MJ, et al. Macrophages regulate corpus luteum development during embryo implantation in mice [J]. J Clin Invest, 2013, 123(8): 3472-3487.
[4]	Liu S, Diao L, Huang C, et al. The role of decidual immune cells on human pregnancy [J]. J Reprod Immunol, 2017, 124: 44-53.
[5]	Li X, Yang A, Huang H, et al. Induction of type 2 T helper cell allergen tolerance by IL-10-differentiated regulatory dendritic cells [J]. Am J Respir Cell Mol Biol, 2010, 42(2): 190-199.
[6]	Darmochwal-Kolarz DA, Kludka-Sternik M, Chmielewski T, et al. The expressions of CD200 and CD200R molecules on myeloid and lymphoid dendritic cells in pre-eclampsia and normal pregnancy [J]. Am J Reprod Immunol, 2012, 67(6): 474-481.
[7]	Rieger L, Honig A, Sutterlin M, et al. Antigen-presenting cells in human endometrium during the menstrual cycle compared to early pregnancy [J]. J Soc Gynecol Investig, 2004, 11(7): 488-493.
[8]	Hsu P, Santner-Nanan B, Dahlstrom JE, et al. Altered decidual DC-SIGN＋ antigen-presenting cells and impaired regulatory T-cell induction in preeclampsia [J]. Am J Pathol, 2012, 181(6): 2149-2160.
[9]	Tirado-Gonzalez I, Munoz-Fernandez R, Blanco O, et al. Reduced proportion of decidual DC-SIGN＋ cells in human spontaneous abortion [J]. Placenta, 2010, 31(11): 1019-1022.
[10]	Dosiou C, Giudice LC. Natural killer cells in pregnancy and recurrent pregnancy loss: endocrine and immunologic perspectives [J]. Endocr Rev, 2005, 26(1): 44-62.
[11]	Vacca P, Vitale C, Montaldo E, et al. CD34^＋ hematopoietic precursors are present in human decidua and differentiate into natural killer cells upon interaction with stromal cells [J]. Proc Natl Acad Sci U S A, 2011, 108(6): 2402-2407.
[12]	Lash GE, Robson SC, Bulmer JN. Review: Functional role of uterine natural killer (uNK) cells in human early pregnancy decidua [J]. Placenta, 2010, 31 Suppl: S87-S92.
[13]	Verma S, King A, Loke YW. Expression of killer cell inhibitory receptors on human uterine natural killer cells [J]. Eur J Immunol, 1997, 27(4): 979-983.
[14]	King A, Allan DS, Bowen M, et al. HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells [J]. Eur J Immunol, 2000, 30(6): 1623-1631.
[15]	Vales-Gomez M, Reyburn HT, Erskine RA, et al. Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E [J]. EMBO J, 1999, 18(15): 4250-4260.
[16]	Fu B, Zhou Y, Ni X, et al. Natural Killer Cells Promote Fetal Development through the Secretion of Growth-Promoting Factors [J]. Immunity, 2017, 47(6): 1100.e6-1113.e6.
[17]	Vacca P, Cantoni C, Vitale M, et al. Crosstalk between decidual NK and CD14＋ myelomonocytic cells results in induction of Tregs and immunosuppression [J]. Proc Natl Acad Sci U S A, 2010, 107(26): 11918-11923.
[18]	Munn DH, Mellor AL. IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and Tolerance [J]. Trends Immunol, 2016, 37(3): 193-207.
[19]	Fu B, Li X, Sun R, et al. Natural killer cells promote immune tolerance by regulating inflammatory TH17 cells at the human maternal-fetal interface [J]. Proc Natl Acad Sci U S A, 2013, 110(3): E231-E240.
[20]	Mjosberg J, Berg G, Jenmalm MC, et al. FOXP3＋ regulatory T cells and T helper 1, T helper 2, and T helper 17 cells in human early pregnancy decidua [J]. Biol Reprod, 2010, 82(4): 698-705.
[21]	Wang SC, Li YH, Piao HL, et al. PD-1 and Tim-3 pathways are associated with regulatory CD8＋ T-cell function in decidua and maintenance of normal pregnancy [J]. Cell Death Dis, 2015, 6: e1738.
[22]	Saito S, Nakashima A, Shima T, et al. Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy [J]. Am J Reprod Immunol, 2010, 63(6): 601-610.
[23]	Hatton RD. TGF-beta in Th17 cell development: the truth is out there [J]. Immunity, 2011, 34(3): 288-290.
[24]	Kimura A, Kishimoto T. IL-6: regulator of Treg/Th17 balance [J]. Eur J Immunol, 2010, 40(7): 1830-1835.
[25]	Levine RJ, Lam C, Qian C, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia [J]. N Engl J Med, 2006, 355(10): 992-1005.
[26]	Wang WJ, Liu F J, Zhang X, et al. Periodic elevation of regulatory T cells on the day of embryo transfer is associated with better in vitro fertilization outcome [J]. J Reprod Immunol, 2017, 119: 49-53.
[27]	Inada K, Shima T, Ito M, et al. Helios-positive functional regulatory T cells are decreased in decidua of miscarriage cases with normal fetal chromosomal content [J]. J Reprod Immunol, 2015, 107: 10-19.
[28]	Rolle L, Memarzadeh Tehran M, Morell-Garcia A, et al. Cutting edge: IL-10-producing regulatory B cells in early human pregnancy [J]. Am J Reprod Immunol, 2013, 70(6): 448-453.
[29]	Menon M, Blair PA, Isenberg DA, et al. A Regulatory Feedback between Plasmacytoid Dendritic Cells and Regulatory B Cells Is Aberrant in Systemic Lupus Erythematosus [J]. Immunity, 2016, 44(3): 683-697.
[30]	Huang B, Faucette AN, Pawlitz MD, et al. Interleukin-33-induced expression of PIBF1 by decidual B cells protects against preterm labor [J]. Nat Med, 2017, 23(1): 128-135.
[31]	Erlebacher A. Immunology of the maternal-fetal interface [J]. Annu Rev Immunol, 2013, 31: 387-411.
[32]	Vento-Tormo R, Efremova M, Botting RA, et al. Single-cell reconstruction of the early maternal-fetal interface in humans [J]. Nature, 2018, 563(7731): 347-353.
[33]	Hughes GC, Choubey D. Modulation of autoimmune rheumatic diseases by oestrogen and progesterone [J]. Nat Rev Rheumatol, 2014, 10(12): 740-751.
[34]	Bouman A, Heineman MJ, Faas MM. Sex hormones and the immune response in humans [J]. Hum Reprod Update, 2005, 11(4): 411-423.
[35]	Bellott DW, Hughes JF, Skaletsky H, et al. Mammalian Y chromosomes retain widely expressed dosage-sensitive regulators [J]. Nature, 2014, 508(7497): 494-499.
[36]	Ostensen M, Villiger PM, Forger F. Interaction of pregnancy and autoimmune rheumatic disease [J]. Autoimmun Rev, 2012, 11(6-7): A437-A446.
[37]	Cutolo M, Sulli A, Capellino S, et al. Sex hormones influence on the immune system: basic and clinical aspects in autoimmunity [J]. Lupus, 2004, 13(9): 635-638.
[38]	Doria A, Ghirardello A, Iaccarino L, et al. Pregnancy, cytokines, and disease activity in systemic lupus erythematosus [J]. Arthritis and rheumatism, 2004, 51(6): 989-995.
[39]	Shapiro-Shelef M, Calame K. Regulation of plasma-cell development [J]. Nat Rev Immunol, 2005, 5(3): 230-242.
[40]	Conti P, Kempuraj D, Kandere K, et al. IL-10, an inflammatory/inhibitory cytokine, but not always [J]. Immunology letters, 2003, 86(2): 123-129.
[41]	Tower C, Crocker I, Chirico D, et al. SLE and pregnancy: the potential role for regulatory T cells [J]. Nature reviews Rheumatology, 2011, 7(2): 124-128.
[42]	De Leo S, Pearce EN. Autoimmune thyroid disease during pregnancy [J]. Lancet Diabetes Endocrinol, 2018, 6(7): 575-586.
[43]	Korevaar TI, de Rijke YB, Chaker L, et al. Stimulation of Thyroid Function by Human Chorionic Gonadotropin During Pregnancy: A Risk Factor for Thyroid Disease and a Mechanism for Known Risk Factors [J]. Thyroid, 2017, 27(3): 440-450.
[44]	Twig G, Shina A, Amital H, et al. Pathogenesis of infertility and recurrent pregnancy loss in thyroid autoimmunity [J]. Journal of autoimmunity, 2012, 38(2-3): J275-J281.
[45]	Medici M, de Rijke YB, Peeters RP, et al. Maternal early pregnancy and newborn thyroid hormone parameters: the Generation R study [J]. The Journal of clinical endocrinology and metabolism, 2012, 97(2): 646-652.
[46]	Kwak-Kim JY, Chung-Bang HS, Ng SC, et al. Increased T helper 1 cytokine responses by circulating T cells are present in women with recurrent pregnancy losses and in infertile women with multiple implantation failures after IVF [J]. Human reproduction (Oxford, England), 2003, 18(4): 767-773.

Please choose a citation manager

Content to export